American Association For Cancer Research

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

More than 10.000 documents for American Association For Cancer Research

- Aeterna Zentaris Announces Results On Aezs-131, a Highly Selective Erk 1/2 Inhibitor Anticancer Compound at American Association for Cancer Research Annual Meeting
QUEBEC CITY, April 5 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that a poster on its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131, was presented at the 102nd annual meeting of the American Association for Cancer Research currently held at the Orange County Convention Center in Orlando, Florida. Poster #3563
- U.S. Newswire
- April 05, 2011
- Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical Research At The American Association For Cancer Research Annual Meeting.
First-ever Data Presentation of PF-04691502, Pfizer's Dual PI3K/mTOR Inhibitor NEW YORK -- Pfizer Oncology announced today that it will present new ...
- Business Wire
- April 14, 2010
- Curis Announces Presentations at 102nd American Association for Cancer Research Annual Meeting 2011.
LEXINGTON, Mass. -- Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates ...
- Business Wire
- March 30, 2011

- Progenics Presents Novel Multiplex PI3-Kinase Inhibitors at American Association for Cancer Research Conference on Protein Translation and Cancer.
TARRYTOWN, N.Y. & CORONADO, Calif. -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the presentation of preclinical data on a series ...
- Business Wire
- February 04, 2010
- Synta Announces Poster Presentations at the American Association for Cancer Research Annual Meeting.
LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing sm...
- Business Wire
- March 16, 2011
- ImmunoGen, Inc. Announces Presentations at the 102nd Annual Meeting of the American Association for Cancer Research.
WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products using its antibody...
- Business Wire
- March 30, 2011
- Advanced Cancer Therapeutics to Present Preclinical Data on Glycolysis Inhibitors at American Association for Cancer Research Annual Meeting.
LOUISVILLE, Ky. -- Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today annou...
- Business Wire
- March 08, 2011
- Senesco Technologies to Present at American Association for Cancer Research's Special Conference.
NEW BRUNSWICK, N.J. -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT), announced today that it will deliver a poster present...
- Business Wire
- January 12, 2011
- Cerulean Pharma Inc. Presents Phase 2a Clinical Data at American Association for Cancer Research (AACR) 102nd Annual Meeting 2011.
CAMBRIDGE, Mass. -- Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced that the Company wi...
- Business Wire
- April 04, 2011
- Spectrum Pharmaceuticals Announces Belinostat Data Presentation at 101st Annual Meeting of the American Association for Cancer Research.
* Data Suggest HDAC Inhibitors, Such as Belinostat, May Be Efficacious in the Treatment of Small Cell Lung Cancer * Results Indicate Synergy With Co...
- Business Wire
- April 21, 2010